Page last updated: 2024-08-24

gemcitabine and Gasser Syndrome

gemcitabine has been researched along with Gasser Syndrome in 52 studies

Research

Studies (52)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	9 (17.31)	18.2507
2000's	23 (44.23)	29.6817
2010's	19 (36.54)	24.3611
2020's	1 (1.92)	2.80

Authors

Authors	Studies
Bäsecke, J; Schoel, G; Schrader, J	1
de Martino, M; Facchini, L; Farina, S; Lucchesi, M; Materassi, M; Melosi, F; Roperto, RM; Sardi, I; Stival, A; Tintori, V	1
Clay, T; Das, A; Dean, A	1
Goecke, H; Méndez, GP; Parodi, C; Vega, J	1
Choi, H; Choi, YJ; Chung, MJ; Han, SH; Kang, H; Kim, JS; Lee, HW; Lee, KJ; Lee, SW; Song, SY	1
Banno, S; Imai, H; Kawai, H; Miura, N; Nobata, H; Suzuki, K; Wakamatsu, R; Yamada, Y	1
Held-Warmkessel, J	1
Aster, RH; Bougie, DW; Curtis, BR; George, JN; Reese, JA; Terrell, DR; Vesely, SK	1
Fimiani, M; Garosi, G; Rongioletti, F; Rubegni, P; Tognetti, L	1
Aristizabal-Alzate, A; Florez-Vargas, AA; Galvez-Cárdenas, KM; Higuita, LM; Nieto-Ríos, JF; Ocampo-Kohn, C; Rincón, CI; Zuluaga-Quintero, M; Zuluaga-Valencia, GA	1
Fernando, M; Goldstein, D; Ritchie, GE	1
Cabezuelo, B; de la Vara Inesta, L; Illescas, ML; Jimeno García, L; López Rubio, ME; Lucas Guillén, E; Martinez Díaz, M; Mateo Bosch, E; Morales Albuja, ME; Rodado Martínez, R	1
Nanjappa, S; Pabbathi, S; Singh, V; Uttamchandani, S	1
Bourquin, V; Delouche, D; Dettwiler, S; Giovannini, M; Guinand, A; Haenni, C; Moll, S	1
Becker, J; Bharthuar, A; Deeb, G; Egloff, L; George, M; Iyer, RV; Lohr, JW	1
Flombaum, CD; Glezerman, I; Kris, MG; Miller, V; Seshan, S	1
Bitzer, M; Fend, F; Finkenwirth, P; Gregor, M; Horger, MS; Lauer, UM; Schick, D	1
Gore, EM; Jones, BS; Marques, MB	1
Gourley, BL; Gupta, P; Mesa, H	1
Bonfill Abella, T; Dalmau Pórtulas, E; Gallardo-Díaz, E; Moya-Horno, I; Pericay Pijaume, C; Querol Niñerola, R; Saigí Grau, E	1
Baba, N; Inaba, T; Ishikawa, H; Ishikawa, S; Kawai, K; Miyoshi, M; Nagano, T; Senoh, T; Takaguchi, K; Watanabe, S; Wato, M	1
Assi, C; Bedenne, L; Jouve, JL; Lepage, C; Sgro, C	1
Omueti-Ayoade, K; Yang, M; Zemtsov, A; Zemtsov, R	1
Audrain, O; Boucher, E; Crouzet, L; Edeline, J; Le Du, F; Raoul, JL	1
Demolin, G; Focan, C; Graas, MP; Houbiers, G; Stultiens, A	1
Joerger, M; Pestalozzi, BC; Walter, RB	1
Alberts, SR; Cha, SS; Fitch, TR; Goldberg, RM; Krook, JE; Mailliard, JA; Moore, DF; Pitot, HC; Sargent, DJ; Townley, PM; Wiesenfeld, M	1
Herchenhorn, D; Rabinowits, G; Rabinowits, M; Torres, W; Weatge, D	1
Genet, D; Labourey, JL; Ly, K; Martin, J; Szelag, JC; Tubiana-Mathieu, N; Vénat-Bouvet, L	1
Clark, JW; Henderson, JM; Humphreys, BD; Magee, CC; Marks, PW; Rennke, HG; Sharman, JP; Zhu, AX	1
Bojko, P; Hense, J; Moritz, T; Müller, S; Nowrousian, MR; Schütt, P; Seeber, S	1
Del Valle, J; Gómez, A; Ruiz, I	1
Algayres, JP; Artru, P; Béchade, D; Bredin, C; Brézault, C; Chaussade, S; Coutant, G; de Gramont, A; Defuentes, G; Desramé, J; Dourthe, LM; Duvic, C; Poirier, JM	1
Herzog, TJ; Lewin, SN; Liapis, H; Mutch, DG; Whitcomb, BP	1
Pfister, C	1
McGee, PJ; Saif, MW	1
Alexandre, J; Chapron, C; Chopin, N; Goldwasser, F; Moachon, L	1
Algayres, JP; Béchade, D; Bredin, C; Defuentes, G; Desramé, J; Dourthe, LM; Duvic, C; Raynaud, JJ	1
Kad, R; Kalra, N; Osama, S	1
Caca, K; Helmchen, U; Schmidt, A; Schwella, N; von Renteln, D	1
Breiteneder, S; Brodowicz, T; Wiltschke, C; Zielinski, CC	1
Daenen, M; Demedts, M; Nackaerts, K; Van Bleyenbergh, P; Vandevelde, A; Vansteenkiste, J	1
Benedetti, F; Casper, ES; Erlandson, RA; Flombaum, CD; Mouradian, JA	1
Huhn, D; Oettle, H; Riess, H; Serke, S	1
Arning, M; Brookfield, W; Fung, MC; Nguyen, B; Storniolo, AM; Vigil, J	1
Ardizzoni, A; Baas, P; Debruyne, C; Giaccone, G; Gridelli, C; Groen, HJ; Lentz, M; Manegold, C; van Marck, EA; van Meerbeeck, JP	1
Choi, M; Göbel, U; Kettritz, R; Schneider, W; Woywodt, A	1
König, P; Kühr, T; Lhotta, K; Rumpelt, HJ; Thaler, J; Wöll, E	1
Goldwasser, F; Gross, M; Hiesse, C; Kriaa, F	1
Eckel, F; Erdmann, J; Lersch, C; Schmidt, B; Schulte-Frohlinde, E	1
Aparicio, M; De Precigout, V; Delclaux, C; Dilhuydy, MS; Pariente, A	1
Bruckner, HW; Kozuch, P; Petryk, M	1

Reviews

11 review(s) available for gemcitabine and Gasser Syndrome

Article	Year
Gemcitabine-induced hemolytic uremic syndrome in pancreatic cancer: a case report and review of the literature. Gut and liver, 2014, Volume: 8, Issue:1 Topics: Antimetabolites, Antineoplastic; Deoxycytidine; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Male; Middle Aged; Pancreatic Neoplasms; Treatment Outcome	2014
Rituximab to treat gemcitabine-induced hemolytic-uremic syndrome (HUS) in pancreatic adenocarcinoma: a case series and literature review. Cancer chemotherapy and pharmacology, 2017, Volume: 79, Issue:1 Topics: Adenocarcinoma; Antimetabolites, Antineoplastic; Deoxycytidine; Gemcitabine; Hemolytic-Uremic Syndrome; Pancreatic Neoplasms; Retrospective Studies; Rituximab	2017
Is therapeutic plasma exchange indicated for patients with gemcitabine-induced hemolytic uremic syndrome? Journal of clinical apheresis, 2009, Volume: 24, Issue:5 Topics: Antimetabolites, Antineoplastic; Breast Neoplasms; Deoxycytidine; Female; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Middle Aged; Plasma Exchange	2009
[A case of hemolytic uremic syndrome after adjuvant chemotherapy with gemcitabine in a patient with pancreatic cancer]. Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology, 2010, Volume: 107, Issue:10 Topics: Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Deoxycytidine; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Male; Middle Aged; Pancreatic Neoplasms	2010
Gemcitabine-associated hemolytic-uremic syndrome. American journal of kidney diseases : the official journal of the National Kidney Foundation, 2002, Volume: 40, Issue:4 Topics: Antimetabolites, Antineoplastic; Deoxycytidine; Female; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Male; Middle Aged; Ovarian Neoplasms; Ribonucleotide Reductases	2002
[Hemolytic uremic syndrome as a complication of gemcitabine treatment: report of six cases and review of the literature]. La Revue de medecine interne, 2005, Volume: 26, Issue:3 Topics: Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Disease Progression; Female; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Male; Middle Aged; Neoplasms; Prognosis; Retrospective Studies	2005
Hemolytic-uremic syndrome associated with gemcitabine: a case report and review of literature. JOP : Journal of the pancreas, 2005, Jul-08, Volume: 6, Issue:4 Topics: Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Male; Pancreatic Neoplasms	2005
Hemolytic-uremic syndrome caused by gemcitabine. Annals of oncology : official journal of the European Society for Medical Oncology, 1998, Volume: 9, Issue:12 Topics: Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Fatal Outcome; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Lung Neoplasms; Male; Middle Aged; Vindesine	1998
[A 42-year-old patient with the hemolytic-uremic syndrome under gemcitabine therapy for an adenocarcinoma of the liver. The hemolytic-uremic syndrome and gemcitabine]. Zeitschrift fur Gastroenterologie, 2000, Volume: 38, Issue:7 Topics: Acute Kidney Injury; Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Deoxycytidine; Disease Progression; Fatal Outcome; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Liver Neoplasms; Male	2000
[Hemolytic-uremic syndrome complicating a long-term treatment with gemcitabine. Report of a case and review of the literature]. La Revue de medecine interne, 2002, Volume: 23, Issue:2 Topics: Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Male; Time Factors	2002
A comprehensive update on the use of chemotherapy for metastatic pancreatic adenocarcinoma. Hematology/oncology clinics of North America, 2002, Volume: 16, Issue:1 Topics: Adenocarcinoma; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow Diseases; Camptothecin; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Deoxycytidine; Docetaxel; Enzyme Inhibitors; Epirubicin; Fluorouracil; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Interferon alpha-2; Interferon-alpha; Irinotecan; Leucovorin; Multicenter Studies as Topic; Organoplatinum Compounds; Paclitaxel; Palliative Care; Pancreatic Neoplasms; Recombinant Proteins; Respiratory Distress Syndrome; Taxoids; Treatment Outcome	2002

Trials

2 trial(s) available for gemcitabine and Gasser Syndrome

Article	Year
Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II study. Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:4 Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease Progression; Female; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms; Survival; Treatment Outcome	2003
A Phase II study of gemcitabine in patients with malignant pleural mesothelioma. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group. Cancer, 1999, Jun-15, Volume: 85, Issue:12 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Disease Progression; Female; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Male; Mesothelioma; Middle Aged; Pleural Neoplasms; Survival Analysis; Treatment Outcome	1999

Article

Year

Gemcitabine and oxaliplatin for metastatic pancreatic adenocarcinoma: a North Central Cancer Treatment Group phase II study.

Annals of oncology : official journal of the European Society for Medical Oncology, 2003, Volume: 14, Issue:4

Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Disease Progression; Female; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Infusions, Intravenous; Male; Middle Aged; Neoplasm Metastasis; Organoplatinum Compounds; Oxaliplatin; Pancreatic Neoplasms; Survival; Treatment Outcome

2003

A Phase II study of gemcitabine in patients with malignant pleural mesothelioma. European Organization for Research and Treatment of Cancer Lung Cancer Cooperative Group.

Cancer, 1999, Jun-15, Volume: 85, Issue:12

Topics: Adult; Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Disease Progression; Female; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Male; Mesothelioma; Middle Aged; Pleural Neoplasms; Survival Analysis; Treatment Outcome

1999

Other Studies

39 other study(ies) available for gemcitabine and Gasser Syndrome

Article	Year
[42-year-old patient with renal insufficience, anemia and thrombocytopenia during chemotherapy]. Deutsche medizinische Wochenschrift (1946), 2020, Volume: 145, Issue:8 Topics: Adult; Anemia; Antineoplastic Agents; Deoxycytidine; Erythrocytes; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Male; Pancreatic Neoplasms; Renal Insufficiency; Thrombocytopenia	2020
Role of eculizumab in a pediatric refractory gemcitabine-induced thrombotic microangiopathy: a case report. Journal of medical case reports, 2017, Jul-27, Volume: 11, Issue:1 Topics: Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Cerebellar Neoplasms; Child, Preschool; Complement Inactivating Agents; Deoxycytidine; Fatal Outcome; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Male; Medulloblastoma	2017
Gemcitabine-induced haemolytic uraemic syndrome in pancreatic adenocarcinoma. BMJ case reports, 2019, Apr-08, Volume: 12, Issue:4 Topics: Adenocarcinoma; Aged; Antimetabolites, Antineoplastic; Antineoplastic Agents, Phytogenic; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Female; Gemcitabine; Glucocorticoids; Hemolytic-Uremic Syndrome; Humans; Methylprednisolone; Paclitaxel; Pancreatic Neoplasms	2019
[Hemolytic-uremic syndrome associated with gemcitabine use: report of one case]. Revista medica de Chile, 2013, Volume: 141, Issue:6 Topics: Antimetabolites, Antineoplastic; Deoxycytidine; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Male; Middle Aged; Pancreatic Neoplasms	2013
Gemcitabine-induced hemolytic uremic syndrome mimicking scleroderma renal crisis presenting with Raynaud's phenomenon, positive antinuclear antibodies and hypertensive emergency. Internal medicine (Tokyo, Japan), 2014, Volume: 53, Issue:5 Topics: Antibodies, Antinuclear; Blood Pressure; Deoxycytidine; Diagnosis, Differential; Emergencies; Female; Gallbladder Neoplasms; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Hypertension, Malignant; Immunosuppressive Agents; Kidney Glomerulus; Middle Aged; Raynaud Disease; Ribonucleotide Reductases; Scleroderma, Systemic	2014
Gemcitabine-associated thrombotic thrombocytopenic purpura and hemolytic uremic syndrome. Oncology nursing forum, 2014, Volume: 41, Issue:5 Topics: Adenocarcinoma; Antibodies, Monoclonal, Murine-Derived; Antihypertensive Agents; Antimetabolites, Antineoplastic; Blood Component Transfusion; Deoxycytidine; Disease Management; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Hypertension; Kidney Failure, Chronic; Nursing Assessment; Pancreatic Neoplasms; Plasmapheresis; Purpura, Thrombotic Thrombocytopenic; Renal Dialysis; Rituximab	2014
Drug-induced thrombotic microangiopathy: Experience of the Oklahoma Registry and the BloodCenter of Wisconsin. American journal of hematology, 2015, Volume: 90, Issue:5 Topics: Ambulatory Care Facilities; Antibodies; Deoxycytidine; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Oklahoma; Organoplatinum Compounds; Oxaliplatin; Pentostatin; Purpura, Thrombotic Thrombocytopenic; Quinine; Registries; Thrombotic Microangiopathies; Vancomycin; Wisconsin	2015
Livedo racemosa and hemolytic uremic syndrome induced by gemcitabine. International journal of dermatology, 2016, Volume: 55, Issue:10 Topics: Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Drug Eruptions; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Leg Ulcer; Male	2016
Hemolytic uremic syndrome due to gemcitabine in a young woman with cholangiocarcinoma. Jornal brasileiro de nefrologia, 2016, Volume: 38, Issue:2 Topics: Adult; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Cholangiocarcinoma; Deoxycytidine; Female; Gemcitabine; Hemolytic-Uremic Syndrome; Humans	2016
Gemcitabine-induced hemolytic-uremic syndrome treated with eculizumab or plasmapheresis: two case reports . Clinical nephrology, 2017, Volume: 87 (2017), Issue:2 Topics: Acute Kidney Injury; Adenocarcinoma; Aged; Antibodies, Monoclonal, Humanized; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Combined Modality Therapy; Deoxycytidine; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Kidney Function Tests; Male; Pancreatic Neoplasms; Plasmapheresis; Purpura, Thrombotic Thrombocytopenic; Renal Dialysis; Treatment Outcome	2017
Thrombotic Microangiopathy in a Patient Treated With Gemcitabine. Cancer control : journal of the Moffitt Cancer Center, 2017, Volume: 24, Issue:1 Topics: Antibodies, Monoclonal, Humanized; Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Male; Middle Aged; Paclitaxel; Pancreatic Neoplasms; Thrombotic Microangiopathies	2017
[Hemolytic uremic syndrome following gemcitabine treatment]. Revue medicale suisse, 2008, Apr-23, Volume: 4, Issue:154 Topics: Antimetabolites, Antineoplastic; Deoxycytidine; Female; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Middle Aged	2008
Rituximab-based therapy for gemcitabine-induced hemolytic uremic syndrome in a patient with metastatic pancreatic adenocarcinoma: a case report. Cancer chemotherapy and pharmacology, 2009, Volume: 64, Issue:1 Topics: Adenocarcinoma; Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Deoxycytidine; Female; Gemcitabine; Glucocorticoids; Hemolytic-Uremic Syndrome; Humans; Immunologic Factors; Middle Aged; Pancreatic Neoplasms; Plasmapheresis; Retrospective Studies; Rituximab; Vincristine	2009
Gemcitabine nephrotoxicity and hemolytic uremic syndrome: report of 29 cases from a single institution. Clinical nephrology, 2009, Volume: 71, Issue:2 Topics: Aged; Aged, 80 and over; Antimetabolites, Antineoplastic; Cause of Death; Creatinine; Deoxycytidine; Disease Progression; Female; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Hypertension, Renal; L-Lactate Dehydrogenase; Male; Middle Aged; Thrombocytopenia	2009
[Thrombotic microangiopathy under an effective treatment with gemcitabine]. Zeitschrift fur Gastroenterologie, 2009, Volume: 47, Issue:3 Topics: Aged; Antimetabolites, Antineoplastic; Carcinoma, Large Cell; Deoxycytidine; Erythrocytes; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Liver Neoplasms; Male; Palliative Care; Pancreatic Neoplasms; Plasmapheresis; Purpura, Thrombotic Thrombocytopenic; Treatment Outcome	2009
Rapid and complete resolution of chemotherapy-induced thrombotic thrombocytopenic purpura/hemolytic uremic syndrome (TTP/HUS) with rituximab. Cancer chemotherapy and pharmacology, 2010, Volume: 65, Issue:5 Topics: Antibodies, Monoclonal; Antibodies, Monoclonal, Murine-Derived; Antimetabolites, Antineoplastic; Blood Cell Count; Blood Platelets; Creatinine; Deoxycytidine; Gemcitabine; Hemoglobins; Hemolytic-Uremic Syndrome; Humans; L-Lactate Dehydrogenase; Male; Middle Aged; Purpura, Thrombotic Thrombocytopenic; Rituximab	2010
Haemolytic uraemic syndrome associated with gemcitabine. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2010, Volume: 12, Issue:5 Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Carcinoma; Deoxycytidine; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Male; Urinary Bladder Neoplasms; Urothelium	2010
Chronic anemia resistant to erythropoietin in a patient treated with gemcitabine showing a hemolytic uremic syndrome (HUS). Gastroenterologie clinique et biologique, 2010, Volume: 34, Issue:11 Topics: Aged; Anemia; Antimetabolites, Antineoplastic; Chronic Disease; Deoxycytidine; Erythropoietin; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Liver Neoplasms; Male; Pancreatic Neoplasms; Treatment Failure	2010
Livedo reticularis as an initial clinical manifestation of gemcitabine-induced hemolytic uremic syndrome. The Journal of dermatology, 2012, Volume: 39, Issue:5 Topics: Antineoplastic Agents; Deoxycytidine; Drug Eruptions; Female; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Livedo Reticularis; Middle Aged; Pancreatic Neoplasms	2012
Haemolytic uremic syndrome and gemcitabine: jaundice is not always progression in cholangiocarcinoma. Acta oncologica (Stockholm, Sweden), 2012, Volume: 51, Issue:5 Topics: Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Cholangiocarcinoma; Deoxycytidine; Disease Progression; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Jaundice; Male; Middle Aged; Prognosis	2012
[Hemolytic uremic syndrome induced by gemcitabine. A poorly recognized complication?]. Revue medicale de Liege, 2012, Volume: 67, Issue:12 Topics: Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Disease Progression; Female; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Male; Middle Aged; Neoplasms; Renal Dialysis; Renal Insufficiency; Time Factors	2012
Fatal pulmonary toxicity in a patient treated with gefitinib for non-small cell lung cancer after previous hemolytic-uremic syndrome due to gemcitabine. Anti-cancer drugs, 2003, Volume: 14, Issue:8 Topics: Aged; Antineoplastic Agents; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Female; Gefitinib; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Lung; Lung Neoplasms; Quinazolines; Tomography, X-Ray Computed	2003
Thrombotic microangiopathy and digital necrosis: two unrecognized toxicities of gemcitabine. Anti-cancer drugs, 2003, Volume: 14, Issue:10 Topics: Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Carcinoma, Transitional Cell; Deoxycytidine; Fingers; Gangrene; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Iloprost; Male; Middle Aged; Pancreatic Neoplasms; Urinary Bladder Neoplasms; Vasodilator Agents	2003
Gemcitabine-associated thrombotic microangiopathy. Cancer, 2004, Jun-15, Volume: 100, Issue:12 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Female; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Hypertension; Incidence; Male; Microcirculation; Middle Aged; Purpura, Thrombotic Thrombocytopenic; Retrospective Studies; Vascular Diseases	2004
Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution. Annals of hematology, 2005, Volume: 84, Issue:2 Topics: Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Deoxycytidine; Disease Progression; Fatal Outcome; Female; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Incidence; Lymphoma; Male; Middle Aged	2005
Gemcitabine and haemolytic-uraemic syndrome. Annals of oncology : official journal of the European Society for Medical Oncology, 2004, Volume: 15, Issue:10 Topics: Antimetabolites, Antineoplastic; Carcinoma; Deoxycytidine; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Male; Middle Aged; Neoplasm Recurrence, Local; Pancreatic Neoplasms	2004
Three cases of hemolytic uremic syndrome in ovarian cancer patients treated with combination gemcitabine and pegylated liposomal doxorubicin. Gynecologic oncology, 2005, Volume: 97, Issue:1 Topics: Antineoplastic Combined Chemotherapy Protocols; Deoxycytidine; Doxorubicin; Female; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Middle Aged; Ovarian Neoplasms	2005
Hemolytic uremic syndrome following prolonged gemcitabine therapy: report of four cases from a single institution. Muller S, Schütt P, Bojko P, Nowrousian MR, Hense J, Seeber S, Moritz T. Ann. Hematol. 2005 Feb; 84(2):110-4. Annals of hematology, 2005, Volume: 84, Issue:9 Topics: Adult; Deoxycytidine; Fatal Outcome; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Kidney Neoplasms; Male; Multiple Organ Failure	2005
Is thrombotic microangiopathy associated with antitumoral activity? Gynecologic oncology, 2006, Volume: 101, Issue:3 Topics: Acute Kidney Injury; Antihypertensive Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Deoxycytidine; Female; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Kidney; Middle Aged; Ovarian Neoplasms	2006
[Is the frequency of hemolytic uremic syndrome as a complication of gemcitabine underestimated? The role of systematic screening]. Gastroenterologie clinique et biologique, 2006, Volume: 30, Issue:2 Topics: Aged; Antimetabolites, Antineoplastic; Deoxycytidine; Female; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Male; Mass Screening; Mesothelioma; Middle Aged; Pancreatic Neoplasms; Peritoneal Neoplasms	2006
Gemcitabine-induced hemolytic uremic syndrome in ovarian carcinoma. International journal of clinical oncology, 2007, Volume: 12, Issue:5 Topics: Antimetabolites, Antineoplastic; Deoxycytidine; Female; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Middle Aged; Ovarian Neoplasms; Treatment Outcome	2007
[A 42 year old patient with bilateral loss of sight and hypertension. Gemcitabine-associated thrombotic microangiopathy (TMA)]. Der Internist, 2008, Volume: 49, Issue:8 Topics: Adrenal Cortex Neoplasms; Adult; Anemia, Hemolytic; Antimetabolites, Antineoplastic; Biopsy; Blindness; Deoxycytidine; Diagnosis, Differential; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Hypertension, Malignant; Kidney; Male; Purpura, Thrombotic Thrombocytopenic	2008
Gemcitabine-induced hemolytic uremic syndrome: a case report. Journal of the National Cancer Institute, 1997, Dec-17, Volume: 89, Issue:24 Topics: Antimetabolites, Antineoplastic; Carcinoma, Non-Small-Cell Lung; Deoxycytidine; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Kidney; Kidney Failure, Chronic; Lung Neoplasms; Male; Middle Aged	1997
Thrombotic microangiopathy as a complication of long-term therapy with gemcitabine. American journal of kidney diseases : the official journal of the National Kidney Foundation, 1999, Volume: 33, Issue:3 Topics: Aged; Antimetabolites, Antineoplastic; Creatinine; Deoxycytidine; Female; Gemcitabine; Haptoglobins; Hemoglobins; Hemolytic-Uremic Syndrome; Humans; Kidney; Male; Microcirculation; Pancreatic Neoplasms; Thrombosis	1999
Elevated reticulocyte count--a clue to the diagnosis of haemolytic-uraemic syndrome (HUS) associated with gemcitabine therapy for metastatic duodenal papillary carcinoma: a case report. British journal of cancer, 1999, Volume: 79, Issue:9-10 Topics: Adult; Anemia; Antimetabolites, Antineoplastic; Carcinoma, Papillary; Deoxycytidine; Duodenal Neoplasms; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Male; Pancreatic Neoplasms; Reticulocyte Count; Thrombocytopenia	1999
A review of hemolytic uremic syndrome in patients treated with gemcitabine therapy. Cancer, 1999, May-01, Volume: 85, Issue:9 Topics: Adult; Aged; Antimetabolites, Antineoplastic; Confounding Factors, Epidemiologic; Deoxycytidine; Female; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Incidence; Male; Middle Aged; Retrospective Studies; Risk Factors; Treatment Outcome; United States	1999
Haemolytic uraemic syndrome after gemcitabine treatment for pancreatic carcinoma. Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association, 1999, Volume: 14, Issue:10 Topics: Antimetabolites, Antineoplastic; Deoxycytidine; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Male; Middle Aged; Pancreatic Neoplasms	1999
Thrombotic microangiopathy with renal failure in two patients undergoing gemcitabine chemotherapy. American journal of nephrology, 1999, Volume: 19, Issue:5 Topics: Adenocarcinoma; Adult; Antimetabolites, Antineoplastic; Bile Duct Neoplasms; Bile Ducts, Intrahepatic; Biopsy, Needle; Cholangiocarcinoma; Deoxycytidine; Fatal Outcome; Female; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Kidney Failure, Chronic; Kidney Glomerulus; Male; Middle Aged; Pancreatic Neoplasms; Renal Dialysis; Ribonucleotide Reductases	1999
Severe hemolytic uremic syndrome in an advanced ovarian cancer patient treated with carboplatin and gemcitabine. Anti-cancer drugs, 1999, Volume: 10, Issue:6 Topics: Antimetabolites, Antineoplastic; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Deoxycytidine; Female; Gemcitabine; Hemolytic-Uremic Syndrome; Humans; Middle Aged; Ovarian Neoplasms	1999